Juvenile Idiopathic Arthritis

Status of Juvenile Idiopathic Arthritis Guideline

2021 JIA Guidelines

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis (final publication anticipated in early 2021)*

* The ACR is developing a new clinical practice guideline for the management of JIA, specifically covering pharmacologic and non-pharmacologic treatments that were not addressed in the ACR/AF 2019 JIA and uveitis guidelines.


2019 JIA Guidelines

JIA
American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis - 2019

Documents related to the 2019 JIA guideline:

JIA Uveitis
American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis - 2019

Documents related to the 2019 JIA uveitis guideline:

arthritis-foundation-logo


2013 JIA Guideline

2013 Update of 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis

Documents related to the 2013 JIA guideline:


2011 JIA Guideline

American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis - 2011

Clinician Guide - 2011

© 2019 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us